ArticleProceedings of the National Academy of Sciences of the United States of America1999

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.

K Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.